22nd Century Total Assets 2012-2026 | XXII
22nd Century total assets from 2012 to 2026. Total assets can be defined as the sum of all assets on a company's balance sheet.
|
22nd Century Annual Total Assets (Millions of US $) |
|
|---|---|
| 2025 | $27 |
| 2024 | $22 |
| 2023 | $28 |
| 2022 | $115 |
| 2021 | $76 |
| 2020 | $52 |
| 2019 | $69 |
| 2018 | $77 |
| 2017 | $80 |
| 2016 | $28 |
| 2015 | $18 |
| 2014 | $22 |
| 2013 | $12 |
| 2012 | $3 |
| 2011 | $2 |
|
22nd Century Quarterly Total Assets (Millions of US $) |
|
|---|---|
| 2026-06-30 | $26 |
| 2026-03-31 | $30 |
| 2025-12-31 | $27 |
| 2025-09-30 | $32 |
| 2025-06-30 | $22 |
| 2025-03-31 | $21 |
| 2024-12-31 | $22 |
| 2024-09-30 | $26 |
| 2024-06-30 | $24 |
| 2024-03-31 | $25 |
| 2023-12-31 | $28 |
| 2023-09-30 | $64 |
| 2023-06-30 | $125 |
| 2023-03-31 | $124 |
| 2022-12-31 | $115 |
| 2022-09-30 | $142 |
| 2022-06-30 | $119 |
| 2022-03-31 | $66 |
| 2021-12-31 | $76 |
| 2021-09-30 | $86 |
| 2021-06-30 | $97 |
| 2021-03-31 | $60 |
| 2020-12-31 | $52 |
| 2020-09-30 | $57 |
| 2020-06-30 | $61 |
| 2020-03-31 | $64 |
| 2019-12-31 | $69 |
| 2019-09-30 | $62 |
| 2019-06-30 | $71 |
| 2019-03-31 | $77 |
| 2018-12-31 | $77 |
| 2018-09-30 | $86 |
| 2018-06-30 | $79 |
| 2018-03-31 | $83 |
| 2017-12-31 | $80 |
| 2017-09-30 | $32 |
| 2017-06-30 | $29 |
| 2017-03-31 | $25 |
| 2016-12-31 | $28 |
| 2016-09-30 | $20 |
| 2016-06-30 | $18 |
| 2016-03-31 | $21 |
| 2015-12-31 | $18 |
| 2015-09-30 | $21 |
| 2015-06-30 | $23 |
| 2015-03-31 | $18 |
| 2014-12-31 | $22 |
| 2014-09-30 | $27 |
| 2014-06-30 | $11 |
| 2014-03-31 | $12 |
| 2013-12-31 | $12 |
| 2013-09-30 | $4 |
| 2013-06-30 | $3 |
| 2013-03-31 | $3 |
| 2012-12-31 | $3 |
| 2012-09-30 | $3 |
| 2012-06-30 | $3 |
| 2012-03-31 | $2 |
| 2011-12-31 | $2 |
| 2011-09-30 | $2 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Consumer Staples | Tobacco Products | $0.001B | $0.018B |
| 22nd Century Group, Inc. is a plant biotechnology company focused on decreasing/increasing the level of nicotine in the tobacco plant through genetic engineering and breeding. The Company is focused on development of smoking cessation aid and owns and controls several patents. The company's products include X-22, a prescription smoking cessation aid, which is a tobacco-based botanical medical product for use as a smoking cessation therapy. 22nd Century Group, Inc. is based in Williamsville, New York. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Philip Morris (PM) | United States | $302.542B | 23.96 |
| Altria (MO) | United States | $116.565B | 12.58 |
| British American Tobacco (BTI) | United Kingdom | $114.738B | 0.00 |
| JAPAN TOB (JAPAY) | Japan | $77.655B | 24.03 |
| Imperial Tobacco Group (IMBBY) | United Kingdom | $25.912B | 0.00 |
| Turning Point Brands (TPB) | United States | $1.356B | 30.05 |
| Universal (UVV) | United States | $1.104B | 21.42 |
| Air Global (AIIR) | United States | $0.288B | 0.00 |
| Ispire Technology (ISPR) | United States | $0.083B | 0.00 |